A full panel drug test is a comprehensive screening that checks your urine, saliva, or hair for a wide range of controlled substances, typically 10 or more drug categories at once. The term “full panel” isn’t a single standardized test but rather refers to the most extensive version of a multi-drug screening, usually a 10-panel, 12-panel, or even broader custom panel. These tests are commonly ordered by employers, courts, pain management clinics, and substance abuse treatment programs.
What a Full Panel Screens For
The most common version is the 10-panel test, which covers five categories of prescription drugs and five categories of street drugs. A standard 10-panel checks for:
- Cannabis: marijuana, hashish, THC extracts
- Cocaine: including crack and freebase forms
- Opioids: heroin, morphine, codeine, oxycodone, hydrocodone
- Benzodiazepines: anti-anxiety medications like Xanax, Valium, Ativan, and Klonopin
- Amphetamines: methamphetamine, speed, and ADHD medications like Adderall and Vyvanse
- Barbiturates: older sedative medications
- Phencyclidine (PCP)
- Methadone
- MDMA (ecstasy)
- Propoxyphene
Panels with 12 or more substances add drugs like buprenorphine, tricyclic antidepressants, or synthetic opioids. Employers and clinics can also customize panels to add whatever substances they consider relevant to their situation.
The Fentanyl Gap
One of the biggest surprises for many people is that standard panels often do not include fentanyl. Because fentanyl is a synthetic opioid with a different chemical structure from drugs like heroin or morphine, it doesn’t reliably trigger a positive on a standard opioid screen. Some employers have already added fentanyl to their custom panels, and as of 2025, the U.S. Department of Transportation has proposed adding fentanyl and its metabolite norfentanyl to the mandatory DOT drug testing panel. Until that rule is finalized, though, a person using fentanyl can pass a standard 10-panel test. This gap has been a growing concern, given that fentanyl is now the leading cause of overdose deaths in the U.S. and increasingly shows up in counterfeit versions of pills like Xanax, Adderall, and oxycodone.
How the Testing Process Works
Full panel drug tests use a two-step process. The first step is an initial screening, which uses a technology called immunoassay. This method works by exposing your sample to antibodies that react to broad drug classes. It’s fast and inexpensive, but it can only identify a general category of drug, not the specific substance. For example, it can flag “amphetamines” but can’t distinguish between methamphetamine and an ADHD medication.
If the initial screen comes back positive, the sample moves to confirmatory testing using a more precise technology called mass spectrometry. This second test identifies the exact drug and its breakdown products in your system, with much lower detection limits and far fewer errors. A result is only reported as positive after both steps confirm the finding.
Each substance has a specific cutoff concentration, measured in nanograms per milliliter, that determines whether a result counts as positive. For the federal workplace testing program, the marijuana cutoff is 50 ng/mL on the initial screen and 15 ng/mL on confirmation. Cocaine’s cutoff is 150 ng/mL initially and 100 ng/mL on confirmation. These thresholds are set to avoid flagging trace or incidental exposure while catching actual use.
How Long Drugs Stay Detectable
Detection windows vary widely depending on the substance, how often you use it, and what type of sample is collected. For urine, the most common specimen type, here’s what to expect:
- Cocaine: 1 to 3 days
- Amphetamines: 2 to 4 days
- Opioids (codeine, morphine): 1 to 3 days
- Benzodiazepines: 3 to 7 days at normal doses, up to 30 days with long-term use
- Cannabis: 1 to 3 days for occasional use, up to 30 days for daily or heavy use
- PCP: 2 to 7 days for a single use, up to 30 days for chronic use
- Alcohol: 12 to 24 hours
- Barbiturates: 1 to 4 days for short-acting types, 10 to 20 days for long-acting types
Other specimen types have very different windows. Saliva testing catches most substances only within 12 to 24 hours of use, and cannabis may only be detectable in saliva for 4 to 10 hours after smoking. Blood tests have a similarly short window of about 12 to 24 hours. Hair testing, on the other hand, can detect drug use from 4 to 6 months ago, making it the longest-range option available.
False Positives and What Causes Them
The initial immunoassay screen is prone to cross-reactivity, meaning certain legal medications can trigger a positive result for a drug you never took. This is one of the main reasons confirmatory testing exists.
For opioid screens specifically, several common medications can cause false positives. These include certain antibiotics in the quinolone family (like ciprofloxacin), the antibiotic rifampin, the blood pressure medication verapamil, and over-the-counter antihistamines containing diphenhydramine (the active ingredient in Benadryl) or doxylamine (found in NyQuil). Eating poppy seeds can also produce a genuine trace of opiates in your system, enough to trigger a positive screen. The antipsychotic quetiapine has been documented to cause false positives on methadone-specific screens.
If you’re taking any prescription or over-the-counter medication, you’ll typically have the opportunity to disclose it to a Medical Review Officer, who reviews positive results and determines whether a legitimate medical explanation exists before reporting the result to your employer.
What “Dilute” Results Mean
If you drank a large amount of water before your test, your sample may come back as “dilute,” meaning the concentration of natural markers in your urine is unusually low. This doesn’t automatically mean you were trying to cheat the test, but it does change what happens next.
A dilute positive is treated the same as a regular positive. No retest is offered. A dilute negative, however, may require a retest depending on how dilute the specimen was. If the concentration of creatinine (a natural waste product in urine) falls between 2 and 5 mg/dL, the reviewing officer will typically order a retest under direct observation. If it’s above 5 mg/dL but still below normal, your employer may choose to have you retest, though they aren’t required to. If that second test also comes back negative and dilute, no further retesting is allowed.
Timelines and Costs
The collection process itself takes about 10 to 20 minutes at a testing site. Most urine test results come back within 2 to 5 days, though more complex panels or tests requiring confirmatory analysis can take longer. If you’re paying out of pocket, collection fees at services like Quest Diagnostics run around $79 for an in-home visit, with lab analysis billed separately. Employer-ordered and court-ordered tests are typically covered by the requesting organization.
Federal vs. Private Employer Panels
The federal government sets mandatory testing guidelines through SAMHSA (the Substance Abuse and Mental Health Services Administration) that apply to all federal employees and workers in safety-sensitive positions like transportation. The current federal panel tests for marijuana, cocaine, opioids (including codeine, morphine, hydrocodone, oxycodone, and heroin markers), PCP, amphetamines, methamphetamine, and MDMA.
Private employers aren’t bound by the federal panel and can test for fewer or more substances. Many private employers use 10-panel or 12-panel tests that include benzodiazepines, barbiturates, and methadone, none of which are on the mandatory federal panel because they’re commonly prescribed. Some have begun adding fentanyl, synthetic cannabinoids, or kratom to their custom panels. The specific drugs included in your “full panel” depend entirely on who ordered the test and why, so if you’re uncertain what you’re being tested for, you can ask the ordering party or the collection site directly.